But the deaths are said to raise no new safety issues or questions about the vaccine’s effectiveness because all represented events that occurred in the general population at a similar rate, the FDA concluded.
“All deaths represent events that occur in the general population of the age groups where they occurred, at a similar rate,” a report says.
The report says data shows the vaccine is just 52 percent effective after the first dose but the rate of success is higher after a second dose.
The Independent UK says trial data published in The Lancet has reaffirmed that the jab is 90 per cent efficacious if administered at a half dose and then at a full dose, or 62 per cent effective if administered in two full doses.
The newspaper says this is the first time large-scale trial results for any coronavirus vaccine is reported.